Cosmetics are FDA-regulated; however, FDA has limited jurisdiction over cosmetics products, and they are not FDA-approved. Products considered cosmetics also can intersect with other product categories under the scope of FDA, such as drugs. Panelists will discuss what products constitute “cosmetics” under the Federal Food, Drug, and Cosmetic Act (FD&C Act), when cosmetics cross into classification as a drug, and advertising claims surrounding the cosmetic industry. Legal issues and challenges in the cosmetic industry, such as Polyfluoroalkyl Substances (PFAS), relevant federal and state laws, and what to expect in the future, also will be addressed.

Get Access

  • +$100 for nonmembers

Internet Explorer and Microsoft Edge are not supported by the checkout process.

Please use Chrome, Firefox, or Safari.  If you are unable to use these browsers, please contact us at 202-371-1420 or [email protected] and we will assist you.


Prashiela Manga, Deputy Director, CFSAN’s Office of Cosmetics and Colors, FDA
Jessica O’Connell, Partner, Covington & Burling LLP
Riëtte van Laack, Director, Hyman, Phelps & McNamara, PC
Moderated by Suzie Trigg, Partner, Haynes Boone LLP

Virtual Learning FAQ

On-demand webinar content is sent via email as soon as we are able to process and verify your order. This usually occurs within 1 business day.


On-demand content can be played back on most devices.


CLE credit is not currently available for pre-recorded sessions.

Related Content